Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,198 public trials 3,223 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

NCT06989437

Conditions
Anorexia, Body Weight, Body Weight Changes, +19 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Central Arkansas Radiation Therapy Institute, dba CARTI Bryant, Arkansas, United States
View all 214 locations
View Trial Details
Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

Conditions
Adenocarcinoma Of Esophagus, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • Ellison Medical Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 105 locations
View Trial Details
Recruiting

ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers

NCT05441163

Conditions
Cancer, Digestive System Diseases, Digestive System Neoplasms, +4 more
Locations
  • CHRU de Tours Tours, Institut Curie, France
  • Institut du cancer Avignon-Provence Avignon, France
  • Institut Bergonié Bordeaux, France
  • Centre de Lutte Contre le Cancer Jean Perrin Clermont-Ferrand, France
View all 18 locations
View Trial Details
Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma

NCT07692152

Conditions
Anal Squamous Cell Carcinoma, Limited-stage, Anus Diseases, Anus Neoplasms, +11 more
Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China
  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen Shenzhen, Guangdong, China
View Trial Details

Related conditions